MELISSA ALEXANDRA GONZALEZ LARA
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism FLORENCE, SC NPI 1831677293
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SC Lilly USA, LLC All categories
General Payments — all program years on this page
$1,744.83
- Category: General Payments
- Program years: PY2023–2024
- Record count: 73
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,291.33 across 58 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,291.33 | 58 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $206.77 | 10 |
| SANOFI-AVENTIS U.S. LLC | $155.78 | 7 |
| Insulet Corporation | $131.61 | 2 |
| Novo Nordisk AS | $103.51 | 7 |
| DEXCOM, INC. | $100.95 | 4 |
| Abbott Laboratories | $87.54 | 4 |
| Corcept Therapeutics | $84.90 | 4 |
| Medtronic, Inc. | $70.86 | 1 |
| Amgen Inc. | $52.92 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $46.29 | 3 |
| BETA BIONICS, INC. | $44.87 | 2 |
| Nevro Corp. | $43.80 | 2 |
| ABBVIE INC. | $33.24 | 2 |
| Ascensia Diabetes Care US Inc. | $26.45 | 1 |
| Rhythm Pharmaceuticals, Inc. | $20.27 | 1 |
| Xeris Pharmaceuticals, Inc. | $20.07 | 1 |
| Ascendis Pharma Inc | $17.56 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $16.12 | 1 |
| CeQur Corporation | $14.00 | 1 |
| GlaxoSmithKline, LLC. | $13.82 | 1 |
By program year
Records — PY2024 (58)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.